Retractable Technologies EV/EBIT RVP

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2019.

Today, Oct 23, 2026: n/m; an operating loss
Last meaningful: 1.3×; Mar 2023
7-year median: 7.1×
7-year range: 1.1× to 106×
Peer median: 8.2×

Retractable Technologies has no meaningful EV/EBIT today: it made an operating loss of $22.7M over the last twelve months.

It was last meaningful in Mar 2023, at 1.3×.

On the days it had one over the last 7 years, its median was 7.1×, from 1.1× in Sep 2022 to 106× in Jul 2020.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2023	1.3×	1.2×	1.5×
2022	1.2×	1.1×	3.6×
2021	3.9×	3.9×	46.2×
2020	25.8×	12.6×	106×
2019	46.7×	41.6×	46.7×

Against its peers

Companies in Medical - Instruments & Supplies nearest Retractable Technologies' size, closest first, today.

Company	EV/EBIT
RVPRetractable Technologies	n/m
NEPHNephros	20.5×
APTAlpha Pro Tech	8.2×
KEQUKewaunee Scientific	7.2×
Peer median	8.2×

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Retractable Technologies

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.